GSTC OTC
GlobeStar Therapeutics Corporation
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -96.5%
5Y: -99.7%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$206K
+37.1% ▲
Capital Expenditures
$0
-100.0% ▼
Free Cash Flow
-$206K
+37.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$6K
-1671.6% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$675K | -$542K | -$10M | -$1M | -$2M |
| Depreciation & Amort. | $472 | $1K | $1K | $55K | $0 |
| Stock-Based Comp. | $68K | $36K | $8M | $509K | $1M |
| Change in Working Capital | $13K | $2K | $221K | $445K | $447K |
| Other Non-Cash Items | $434K | $225K | $695K | $152K | $60K |
| Operating Cash Flow | -$260K | -$240K | -$751K | -$327K | -$206K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | -$2K | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$2K | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $269K | $222K | $95K | $0 | $55K |
| Stock Repurchased | -$269K | $0 | $0 | $0 | $0 |
| Dividends Paid | -$2M | $0 | $0 | $0 | $0 |
| Other Financing | $2M | $0 | $0 | $12K | -$1K |
| Financing Cash Flow | $269K | $222K | $676K | $327K | $199K |
| Net Change in Cash | $9K | -$19K | -$75K | $405 | -$6K |
| Cash End of Period | $100K | $81K | $6K | $6K | $0 |
| Free Cash Flow | -$260K | -$242K | -$751K | -$327K | -$206K |